Analysis of absorption enhancers in epithelial cell models

Annals of the New York Academy of Sciences

Volumn 1258, Issue 1, 2012, Pages 86-92

  Rosenthal, Rita ^a   Heydt, Miriam S ^a   Amasheh, Maren ^a   Stein, Christoph ^a   Fromm, Michael ^a   Amasheh, Salah ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chitosan; Claudins; HT 29 B6; Tight junctions

Indexed keywords

BACTERIAL TOXIN; CALCIUM CHELATING AGENT; CHITOSAN; CLAUDIN; FATTY ACID;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; CLOSTRIDIUM PERFRINGENS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; EPITHELIUM CELL; MACROMOLECULE; TIGHT JUNCTION;

BACTERIA (MICROORGANISMS);

EID: 84861995150     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06562.x     Document Type: Article

References (60)

1. Windsor, E. & G.E. Cronheim 1961. Gastro-intestinal absorption of heparin and synthetic heparinoids. Nature 190: 263-264.
2. Duan, X. & S. Mao 2010. New strategies to improve the intranasal absorption of insulin. Drug Discov. Today 15: 416-427.
3. Zhou, X., D. Liu, H. Liu, et al 2010. Effect of low molecular weight chitosans on drug permeation through mouse skin: 1. Transdermal delivery of baicalin. J. Pharm. Sci. 99: 2991-2998.
4. Rosenthal, R., D. Günzel, C. Finger, et al 2012. The effect of chitosan on transcellular and paracellular mechanisms in the intestinal epithelial barrier. Biomaterials 33: 2791-2800.
5. Döring, F., J. Walter, J. Will, et al 1998. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. J. Clin. Invest. 101: 2761-2767.
6. +/peptide symporter PepT1 expressed in Xenopus laevis oocytes. J. Membr. Biol. 155: 247-256.
7. Döring, F., J. Will, S. Amasheh, et al 1998. Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter. J. Biol. Chem. 273: 23211-23218.
8. Furuse, M., T. Hirase, M. Itoh, et al 1993. Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol. 123: 1777-1788.
9. Ikenouchi, J., M. Furuse, K. Furuse, et al 2005. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J. Cell Biol. 171: 939-945.
10. Furuse, M., K. Fujita, T. Hiiragi, et al 1998. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 141: 1539-1550.
11. Markov, A.G., A. Veshnyakova, M. Fromm, et al 2010. Segmental expression of claudin proteins correlates with tight junction barrier properties in rat intestine. J. Comp. Physiol. B 180: 591-598.
12. Yuki, T., A. Hachiya, A. Kusaka, et al 2011. Characterization of tight junctions and their disruption by UVB in human epidermis and cultured keratinocytes. J. Invest. Dermatol. 131: 744-752.
13. Nitta, T., M. Hata, S. Gotoh, et al 2003. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161: 653-660.
14. Takano, K., T. Kojima, M. Go, et al 2005. HLA-DR- and CD11c-positive dendritic cells penetrate beyond well-developed epithelial tight junctions in human nasal mucosa of allergic rhinitis. J. Histochem. Cytochem. 53: 611-619.
15. Markov, A.G., N.M. Kruglova, Y.A. Fomina, et al 2011. Altered expression of tight junction proteins in mammary epithelium after discontinued suckling in mice. Pflügers Arch. 463: 391-398.
16. Markov, A.G., M.A. Voronkova, G.N. Volgin, et al 2011. Tight junction proteins contribute to barrier properties in human pleura. Respir. Physiol. Neurobiol. 175: 331-335.
17. Amasheh, S., M. Fromm & D. Günzel 2011. Claudins of intestine and nephron-a correlation of molecular tight junction structure and barrier function. Acta Physiol. (Oxf) 201: 133-140.
18. Furuse, M., K. Furuse, H. Sasaki & S. Tsukita 2001. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J. Cell Biol. 153: 263-272.
19. Schulzke, J.D., A.H. Gitter, J. Mankertz, et al 2005. Epithelial transport and barrier function in occludin-deficient mice. Biochim. Biophys. Acta 1669: 34-42.
20. Amasheh, S., N. Meiri, A.H. Gitter, et al 2002. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J. Cell Sci. 115: 4969-4976.
21. Rosenthal, R., S. Milatz, S.M. Krug, et al 2010. Claudin-2, a component of the tight junction, forms a paracellular water channel. J. Cell Sci. 123: 1913-1921.
22. Krug, S.M., D. Günzel, M.P. Conrad, et al 2012. Claudin-17 forms tight junction channels with distinct anion selectivity. Cell. Mol. Life Sci. DOI:
23. Amasheh, S., S. Dullat, M. Fromm, et al 2009. Inflamed pouch mucosa possesses altered tight junctions indicating recurrence of inflammatory bowel disease. Int. J. Colorectal Dis. 24: 1149-1156.
24. Furuse, M., M. Hata, K. Furuse, et al 2002. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J. Cell Biol. 156: 1099-1111.
25. Milatz, S., S.M. Krug, R. Rosenthal, et al 2010. Claudin-3 acts as a sealing component of the tight junction for ions of either charge and uncharged solutes. Biochim. Biophys. Acta Biomembr. 1798: 2048-2057.
26. Amasheh, S., T. Schmidt, M. Mahn, et al 2005. Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells. Cell Tiss. Res. 321: 89-89.
27. Tsukita, S., Y. Yamazaki, T. Katsuno, et al 2008. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 27: 6930-6938.
28. Kondoh, M., T. Yoshida, H. Kakutani & K. Yagi 2008. Targeting tight junction proteins-significance for drug development. Drug. Discov. Today 13: 180-186.
29. Evans, M.J., T. von Hahn, D.M. Tscherne, et al 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446: 801-805.
30. Lu, T.S., H.K. Avraham, S. Seng, et al 2008. Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells. J. Immunol. 181: 6406-6416.
31. Amasheh, M., A. Fromm, S.M. Krug, et al 2010. TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling. J. Cell Sci. 123: 4145-4155.
32. + absorption defends from paracellular back-leakage by claudin-8 upregulation. Biochem. Biophys. Res. Commun. 378: 45-50.
33. Fujita, K., J. Katahira, Y. Horiguchi, et al 2000. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett. 476: 258-261.
34. Krug, S.M., M. Fromm & D. Günzel 2009. Two-path impedance spectroscopy for measuring paracellular and transcellular epithelial resistance. Biophys. J. 97: 2202-2211.
35. Fasano, A., S. Uzzau, C. Fiore & K. Mararetten 1997. The enterotoxic effect of Zonula Occludens toxin on rabbit small intestine involves the paracellular pathway. Gastroentrology 112: 839-846.
36. Rothen-Rutishauser, B., F.K. Riesen, A. Braun, et al 2002. Dynamics of tight and adherens junctions under EGTA treatment. J. Membr. Biol. 188: 151-162.
37. Yu, D., A.M. Marchiando, C.R. Weber, et al 2010. MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proc. Natl. Acad. Sci. USA 107: 8237-8241.
38. Sonoda, N., M. Furuse, H. Sasaki, et al 1999. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J. Cell Biol. 147: 195-204.
39. Takahashi, A., Y. Saito, M. Kondoh, et al 2012. Creation and biochemical analysis of a broad-specific claudin binder. Biomaterials 33: 3464-3474.
40. Kominsky, S.L., M. Vali, D. Korz, et al 2004. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am. J. Pathol. 164: 1627-1633.
41. Yao, J., J.P. Zhou, Q.N. Ping, et al 2008. Distribution of nobiletin chitosan-based microemulsions in brain following i.v. injection in mice. Int. J. Pharm. 352: 256-262.
42. Yeh, T.H., L.W. Hsu, M.T. Tseng, et al 2011. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. Biomaterials 32: 6164-6173.
43. Kotze, A.F., H.L. Luessen, A.G. de Boer, et al 1999. Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments. Eur J. Pharm. Sci. 7: 145-151.
44. Schipper, N.G., S. Olsson, J.A. Hoogstraate, et al 1997. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm. Res. 14: 923-929.
45. Ranaldi, G., I. Marigliano, I. Vespignani, et al 2002. The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line. J. Nutr. Biochem. 13: 157-167.
46. Smith, J., E. Wood & M. Dornish 2004. Effect of chitosan on epithelial cell tight junctions. Pharm. Res. 21: 43-49.
47. Dodane, V. & B. Kachar 1996. Identification of isoforms of G proteins and PKC that colocalize with tight junctions. J. Membr. Biol. 149: 199-209.
48. Smith, J.M., M. Dornish & E.J. Wood 2005. Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption. Biomaterials 26: 3269-3276.
49. Dorkoosh, F.A., C.A. Broekhuizen, G. Borchard, et al 2004. Transport of octreotide and evaluation of mechanism of opening the paracellular tight junctions using superporous hydrogel polymers in Caco-2 cell monolayers. J. Pharm. Sci. 93: 743-752.
50. Thanou, M., J.C. Verhoef & H.E. Junginger 2001. Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Deliv. Rev. 50: S91-101.
51. Thanou, M., M.T. Nihot, M. Jansen, et al 2001. Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo. J. Pharm. Sci. 90: 38-46.
52. Sandri, G., M.C. Bonferoni, S. Rossi, et al 2010. Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties. AAPS PharmSciTech. 11: 362-371.
53. Kudsiova, L. & M.J. Lawrence 2008. A comparison of the effect of chitosan and chitosan-coated vesicles on monolayer integrity and permeability across Caco-2 and 16HBE14o-cells. J. Pharm. Sci. 97: 3998-4010.
54. Lindmark, T., J.D. Soderholm, G. Olaison, et al 1997. Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate. Pharm. Res. 14: 930-935.
55. Lindmark, T., Y. Kimura & P. Artursson 1998. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol. Exp. Ther. 284: 362-369.
56. Kurasawa, M., S. Kuroda, N. Kida, et al 2009. Regulation of tight junction permeability by sodium caprate in human keratinocytes and reconstructed epidermis. Biochem. Biophys. Res. Commun. 381: 171-175.
57. Bjarnason, I. 1994. Intestinal permeability. Gut 35: S18-S22.
58. Wolfe, M.M., D.R. Lichtenstein & G. Singh 1999. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 340: 1888-1899.
59. Kondoh, M., A. Masuyama, A. Takahashi, et al 2005. A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol. Pharmacol. 67: 749-756.
60. Tomita, M., M. Hayashi & S. Awazu 1996. Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells. J. Pharm. Sci. 85: 608-611.